Other news to note for Aug. 2, 2022
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Aim Immunotech, Altamira, Aurinia, Bausch Health, Bharat, Biocytogen, Brii, Dompé, Excellgene, Gigagen, Grifols, Icosavax, Intas, Liberothera, Moderna, Oyagen, Prestige, Rona, Sandoz, Sanofi, Sun, Sunshine, Teva, Therapeutic Solutions International, Tonix.
Other news to note for Aug. 2, 2022
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Aim Immunotech, Altamira, Aurinia, Bausch Health, Bharat, Biocytogen, Brii, Dompé, Excellgene, Gigagen, Grifols, Icosavax, Intas, Liberothera, Moderna, Oyagen, Prestige, Rona, Sandoz, Sanofi, Sun, Sunshine, Teva, Therapeutic Solutions International, Tonix.